| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.055 | 0.2 |